Interpretation of the “Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Polycystic Ovary Syndrome (2024 Edition)”

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine metabolic disease in women, which seriously affects women’s quality of life, fertility and long-term health. The clinical characteristics of PCOS are continuous thin ovulation or anovulation, hyperandrogenism or hyperandrogenemia, and ovarian polycystic changes, often accompanied by insulin resistance and obesity. Currently, Western medicine focuses on symptomatic treatments such as reducing androgen, adjusting menstrual cycle, and improving insulin resistance. Studies have confirmed that TCM syndrome differentiation has characteristics and advantages in improving metabolic disorders, reducing body weight, restoring natural ovulation, etc. However, the classification of TCM syndrome differentiation is not uniform, and the diagnosis and treatment plan has not been recognized by the industry. Therefore, it is of great clinical value and guiding significance to establish a standardized diagnosis and treatment plan suitable for PCOS population in China.